Seeing Machines H1 FY2026 Update: Automotive Growth Ahead of EU GSR Deadline

New awards and tech milestones

• European expansion: an existing European Tier 1/OEM programme has been expanded, with an expected additional US$10 million in initial lifetime value. Production is expected to commence in 2028.
• Japan momentum: a new production award with Mitsubishi Electric Mobility Corporation, and an advanced development project with another prominent Japanese OEM with a formal award expected in H1 CY2026.
• Product leadership: launch of impairment detection capability at the MADD Conference in the US, targeting non-transient impairment including alcohol – a clear focus area for US regulators. Plus, a successful debut of the next-gen 3D Cabin Perception Mapping at CES 2026.

These wins and showcases reinforce the competitive moat: proven in-market volumes today, and feature-rich cabin perception for tomorrow’s semi-automated and safety-first vehicles.

Aftermarket and ARR: Guardian keeps ticking up

ARR grew to US$14.0 million from US$13.5 million at 30 June 2025, supported by Guardian – Seeing Machines’ aftermarket safety solution for commercial fleets. Recurring revenue matters because it smooths the cycle between automotive design wins and production ramps.

• US$1.8 million Guardian order from a leading North American autonomous vehicle operator to expand testing across more US locations.
• Major order for 1,100 Guardian units from a US-based multinational fleet operator, with discussions underway for further expansion this calendar year.
• First US Guardian fleet win in partnership with Mitsubishi Electric Automotive America, plus a new Future Mobility Group to serve autonomous and next‑gen mobility customers.

While ARR’s step-up is modest, the order flow suggests further runway. If those discussions convert, ARR could begin to reflect it in subsequent periods.

Cash, working capital and runway: the tricky bit

Cash fell by US$19.1 million in H1 to US$3.4 million at 31 December 2025, driven by approximately US$13.1 million operating outflow, US$5.0 million working capital build (mainly inventory), and US$1.0 million deferred consideration for the Asaphus acquisition. Management expects inventories to unwind in H2 as deliveries are met.

Post period end, the Company received approximately US$14.1 million as an accelerated lump sum royalty from a Tier 1 customer under an existing Automotive Program Guarantee. That eases near-term liquidity and bridges to the expected H2 profitability and cash generation.

Net-net: the cash position at the balance date was tight, but the post-period receipt and expected working capital unwind, combined with a positive Adjusted EBITDA outlook for Q3 and H2, improve the picture. Still, execution on production ramps and collections now matters more than ever.

Outlook: approaching the GSR inflection

Management says the Company continues to trade in line with market expectations. With GSR implementation imminent, automotive production volumes are expected to increase materially over coming quarters, supporting accelerating royalty volume, expanding recurring revenues and improved operating leverage as OEM compliance strategies move into production.

Adjusted EBITDA is expected to be positive in Q3 and for H2 FY2026. The strategy is clear: ride the regulatory tailwind with superior DMS/OMS, convert pipeline into production, and keep tightening costs after last year’s reorganisation benefits.

My take: positives, pressures, and what to watch

What’s working

• Royalty flywheel: 62% production volume growth and 43% royalty growth are the right metrics heading into GSR.
• Market position: 4,818,731 cars on the road underscores scale and credibility with OEMs and Tier 1s.
• Pipeline depth: programme expansion in Europe, wins in Japan, and advanced features showcased at CES and MADD point to sustained relevance.
• Operational discipline: lower operating expenses versus the prior period and a path to positive Adjusted EBITDA in H2.

Where I’m cautious

• Cash timing: US$3.4 million at 31 December 2025 was low before the post-period US$14.1 million receipt. Execution on collections and inventory unwind needs to land as planned.
• Revenue mix optics: headline revenue down due to lower NRE and no prior licence revenue. That’s fine if royalties keep scaling – but near-term optics can still spook the market.
• Award conversion: the advanced development project in Japan awaits a formal award in H1 CY2026. Investors will want to see signatures and timelines.

Key definitions (quick and simple)

• DMS/OMS: Driver/Occupant Monitoring Systems – cameras and AI that detect attention and impairment.
• GSR: EU General Safety Regulation mandating camera-based DMS for all newly registered vehicles from 7 July 2026.
• NRE: Non-recurring engineering – one-off design and development fees early in a programme.
• ARR: Annualised Recurring Revenue – contracted, repeatable revenue, mainly from Guardian.
• Adjusted EBITDA: Earnings before interest, tax, depreciation and amortisation, adjusted for certain items – a proxy for operating cash profitability.

What could move the share price next

• Formal Japanese OEM award in H1 CY2026 and any additional programme wins.
• H1 FY2026 Results in March 2026, particularly detail on cash, inventories and royalty trajectory.
• Visible GSR-driven production ramps and incremental royalty disclosures.
• Further Guardian orders converting into ARR growth.
• Confirmation of positive Adjusted EBITDA in Q3 and H2, and evidence of positive cashflow in H2 FY2026.

Overall, this is the classic pre-inflection setup: softer engineering revenue, stronger volume royalties, and a regulatory catalyst dead ahead. If execution holds, Seeing Machines looks set to benefit from the GSR wave while building a broader cabin intelligence platform for the long run.